行情

NURO

NURO

神经矩阵医疗
NASDAQ

实时行情|Nasdaq Last Sale

4.780
-0.530
-9.98%
盘后: 4.890 +0.11 +2.30% 19:52 01/21 EST
开盘
5.06
昨收
5.31
最高
5.43
最低
4.760
成交量
66.02万
成交额
--
52周最高
38.75
52周最低
2.580
市值
3,176.50万
市盈率(TTM)
-13.7475
分时
5日
1月
3月
1年
5年
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2021 Financial Results Conference Call
WOBURN, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 fourth quarter and full year financial results before the opening of the market on January 27, 2022. The Company will host a c...
GlobeNewswire · 2天前
CLFD, NURO and PIXY among mid-day movers
Gainers: Zogenix (NASDAQ:ZGNX) +67%. Vivos Therapeutics (NASDAQ:VVOS) +48%. G Medical Innovations (NASDAQ:GMVD) +46%. ShiftPixy (NASDAQ:PIXY) +31%. Splash Beverage (NYSE:SBEV) +28%. New Pacific (NYSE:NEWP) +18%. Gamida Cell (NASDAQ:GMDA) +18%. Vaxxinity (N...
Seekingalpha · 3天前
35 Stocks Moving In Wednesday's Mid-Day Session
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion.
Benzinga · 3天前
Zogenix, Vivos lead healthcare gainers; Cardiff Oncology, Yumanity among losers
Gainers: Zogenix (NASDAQ:ZGNX) +68%. Vivos Therapeutics (NASDAQ:VVOS) +33%. Gamida Cell (NASDAQ:GMDA) +21%. Vaxxinity (NASDAQ:VAXX) +13%. Renalytix (NASDAQ:RNLX) +11%. Losers: Cardiff Oncology (NASDAQ:CRDF) -24%. Yumanity Therapeutics (NASDAQ:YMTX) -17%. O...
Seekingalpha · 3天前
SLI, YMTX and NURO among pre market losers
Yumanity Therapeutics (NASDAQ:YMTX) -12% reports partial clinical hold by U.S. FDA on multidose clinical trials for YTX-7739. Cardiff Oncology (NASDAQ:CRDF) -12% posts new data for lead program in colorectal cancer. Ensysce Biosciences (NASDAQ:ENSC) -12%.
Seekingalpha · 3天前
Mid-Afternoon Market Update: Dow Dips 500 Points; NeuroMetrix Shares Spike Higher
Toward the end of trading Tuesday, the Dow traded down 1.4% to 35,410 while the NASDAQ fell 2.12% to 14,577.79. The S&P also fell, dropping, 1.60% to 4,588.10.
Benzinga · 4天前
DWAC, BTCS and BTCM among mid-day movers
Gainers: Brickell Biotech (NASDAQ:BBI) +69%. Mainz (NASDAQ:MYNZ) +34%. NeuroMetrix (NASDAQ:NURO) +33%. Activision Blizzard (NASDAQ:ATVI) +25%. Vinco Ventures (NASDAQ:BBIG) +21%. DatChat (NASDAQ:DATS) +19%. InnSuites Hospitality Trust (NYSE:IHT) +18%. Digit...
Seekingalpha · 4天前
Mid-Day Market Update: Nasdaq Tumbles 250 Points; Activision Blizzard Shares Jump
Midway through trading Tuesday, the Dow traded down 1.58% to 35,343.17 while the NASDAQ fell 1.70% to 14,640.00. The S&P also fell, dropping, 1.57% to 4,589.66.
Benzinga · 4天前
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解NURO最新的财务预测,通过NURO每股收益,每股净资产,每股现金流等数据分析神经矩阵医疗近期的经营情况,然后做出明智的投资选择。
分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
100.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测NURO价格均价为50.00,最高价位50.00,最低价为50.00。
最高50.00
均价50.00
最低50.00
现价4.780
EPS
实际EPS
预期EPS
-0.10-0.08-0.05-0.03
Q3 2020
Q4 2020
Q1 2021
Q2 2021
Q3 2021
机构持股
总机构数: 35
机构持股: 79.99万
持股比例: 12.04%
总股本: 664.54万
类型机构数股数
增持
6
37.43万
建仓
11
13.37万
减持
4
9.53万
平仓
4
5.89万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
-0.93%
医疗设备和用品
-1.50%
高管信息
Chairman/Chief Executive Officer/President/Secretary/Director
Shai Gozani
Chief Financial Officer/Senior Vice President/Treasurer
Thomas Higgins
Independent Director
David Goodman
Independent Director
Nancy Katz
Independent Director
David Van Avermaete
公告日期
每股分红
除权日期
2007/03/14
每股分红:USD 0.15
2007/03/28
NURO 简况
NeuroMetrix, Inc.是一家结合生物电与数字医学治疗慢性疾病(包括慢性疼痛、睡眠障碍和糖尿病)的医疗保健公司。该公司从事医疗器械、消耗品以及配件的销售业务。该公司主要包括两类产品:可穿戴神经刺激治疗设备和护理点神经病理诊断测试。该公司的产品包括ADVANCE NCS/EMG系统(ADVANCE系统)、Quell、SENSUS和DPNCheck。Quell是一种用于缓解慢性难治性疼痛(如下背部疼痛以及糖尿病引起的神经痛)的可穿戴设备。SENSUS疼痛治疗装置(Quell的技术前身)是一种通过经皮电神经刺激(TENS)缓解慢性难治性疼痛的处方神经刺激设备。DPNCheck是一种定量神经传导测试。ADVANCE系统是一个传统神经传导研究平台。

微牛提供Neurometrix Inc(NASDAQ-NURO)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的NURO股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NURO股票基本功能。